Caretrust REIT (NASDAQ:CTRE) Announces Earnings Results

Caretrust REIT (NASDAQ:CTRE) released its earnings results on Thursday. The real estate investment trust reported ($0.11) EPS for the quarter, missing analysts’ consensus estimates of $0.34 by ($0.45), Fidelity Earnings reports. Caretrust REIT had a return on equity of 8.08% and a net margin of 39.70%. The business had revenue of $33.31 million for the quarter, compared to analyst estimates of $43.64 million. During the same period in the prior year, the firm posted $0.32 EPS. Caretrust REIT’s revenue was down 15.7% on a year-over-year basis. Caretrust REIT updated its FY20 guidance to $1.36 to $1.38 EPS.

Shares of CTRE stock traded down $0.96 on Friday, hitting $20.51. The stock had a trading volume of 3,289,200 shares, compared to its average volume of 886,366. The firm has a market cap of $2.16 billion, a P/E ratio of 16.02 and a beta of 0.66. The company has a fifty day moving average price of $23.52 and a two-hundred day moving average price of $23.84. Caretrust REIT has a twelve month low of $17.71 and a twelve month high of $25.54. The company has a current ratio of 0.97, a quick ratio of 0.97 and a debt-to-equity ratio of 0.56.

The company also recently declared a — dividend, which was paid on Tuesday, October 15th. Stockholders of record on Monday, September 30th were issued a $0.225 dividend. This represents a dividend yield of 3.9%. The ex-dividend date was Friday, September 27th. Caretrust REIT’s dividend payout ratio (DPR) is 70.31%.

A number of research firms have commented on CTRE. Zacks Investment Research raised shares of Caretrust REIT from a “hold” rating to a “buy” rating and set a $25.00 target price for the company in a report on Wednesday. BMO Capital Markets reaffirmed a “buy” rating and set a $26.00 target price on shares of Caretrust REIT in a report on Wednesday, August 7th. Capital One Financial raised shares of Caretrust REIT from an “equal weight” rating to an “overweight” rating and set a $25.00 target price for the company in a report on Wednesday, August 21st. Barclays began coverage on shares of Caretrust REIT in a report on Tuesday, September 3rd. They set an “overweight” rating and a $26.00 target price for the company. Finally, ValuEngine lowered shares of Caretrust REIT from a “buy” rating to a “hold” rating in a report on Thursday, August 1st. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and seven have issued a buy rating to the company. Caretrust REIT has a consensus rating of “Buy” and an average target price of $25.50.

Caretrust REIT Company Profile

CareTrust REIT, Inc is a self-administered, publicly-traded real estate investment trust engaged in the ownership, acquisition and leasing of seniors housing and healthcare-related properties. With 199 net-leased healthcare properties and three operated seniors housing properties in 27 states, CareTrust is pursuing opportunities across the nation to acquire properties that will be leased to a diverse group of local, regional and national seniors housing operators, healthcare services providers, and other healthcare-related businesses.

Featured Story: The benefits and drawbacks of dollar cost averaging

Earnings History for Caretrust REIT (NASDAQ:CTRE)

Receive News & Ratings for Caretrust REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Caretrust REIT and related companies with's FREE daily email newsletter.